B. Subotić

发表

Renal dysfunction as intrahospital prognostic indicator in acute pulmonary embolism.

J. Matijašević, B. Dzudovic, S. Obradovic, 2019, International journal of cardiology.

Association of different electrocardiographic patterns with shock index, right ventricle systolic pressure and diameter, and embolic burden score in pulmonary embolism.

N. Ratković, S. Vukotić, Danijela Vraneš, 2016, Vojnosanitetski pregled.

Pulmonary embolism bleeding score index (PEBSI): A new tool for the detection of patients with low risk for major bleeding on thrombolytic therapy.

A. Neskovic, J. Matijašević, B. Dzudovic, 2022, Thrombosis research.

Ultrasound assisted thrombolysis in intermediate-risk patients with pulmonary thromboembolism

Uros M. Miladinovic, J. Matijašević, N. Rančić, 2020, Acta cardiologica.

Caveats in the Management of Patients with Acute Pulmonary Thromboembolism and Possible New Pathways

B. Dzudovic, S. Obradovic, B. Subotić, 2017 .

First experiences in the implementation of rivaroxaban in patients with pulmonary thromboembolism who received thrombolytic therapy

N. Ratković, S. Vukotić, Lidija Torbica, 2014 .

Renovascular hypertension: Case report

M. Marjanović, B. Subotić, G. Nikčević, 2012 .

Symptomatic artery disease as a predictor of in-hospital and 6-month prognosis in patients with acute pulmonary embolism

B. Dzudovic, S. Obradovic, D. Stanojević, 2017 .

Relationship between age and clinical and laboratory features at admission in patients with pulmonary embolism

Danijela Vraneš, J. Matijašević, B. Dzudovic, 2017 .

Electrocardiography changes and their significance during treatment of patients with intermediate-high and high-risk pulmonary embolism

B. Dzudovic, S. Obradovic, B. Subotić, 2020, European heart journal. Acute cardiovascular care.

Differences between activities of coagulation factors after one month of therapy with different direct oral anticoagulant in pulmonary embolism patients

B. Dzudovic, S. Obradovic, B. Subotić, 2018, Journal of clinical pharmacy and therapeutics.

Sex‐related difference in the prognostic value of syncope for 30‐day mortality among hospitalized pulmonary embolism patients

M. Dekleva, J. Matijašević, B. Dzudovic, 2020, The clinical respiratory journal.

. The role of N-terminal pro-brain natriuretic peptide in the assessment of right ventricular dysfunction in patients with acute pulmonary embolism: Results from Serbian University Pulmonary Embolism Registry (Super)

B. Stanetić, J. Matijašević, N. Kocev, 2019, Respiratio.

Predictive value of admission glycemia in diabetics with pulmonary embolism compared to non-diabetic patients

A. Neskovic, J. Matijašević, B. Dzudovic, 2022, Acta Diabetologica.

A Prospective Trial with Long Term Follow-up of Patients With Severe, Steroid-Resistant Ulcerative Colitis Who Received Induction Therapy With Cyclosporine and Were Maintained With Vedolizumab.

A. Gils, B. Subotić, D. Tarabar, 2022, Inflammatory bowel diseases.

DOP049 Combination therapy of cyclosporine and vedolizumab is effective and safe for severe, steroid-resistant ulcerative colitis patients: A prospective study

D. Rubin, B. Subotić, Z. Milenkovic, 2018 .

New-Onset Paroxysmal Atrial Fibrillation in the Setting of Acute Pulmonary Embolism Is Associated with All-Cause Hospital Mortality in Women but Not in Men

A. Neskovic, J. Marinković, J. Matijašević, 2023, Diagnostics.

Biomarkers for the prediction of early pulmonary embolism related mortality in spontaneous and provoked thrombotic disease.

J. Matijašević, N. Kocev, B. Dzudovic, 2019, Clinica chimica acta; international journal of clinical chemistry.

The significance of C-reactive protein for the prediction of net-adverse clinical outcome in patients with acute pulmonary embolism

I. Soldatovic, B. Dzudovic, S. Obradovic, 2020, Vojnosanitetski pregled.